ZIPPZ CBD Taps Renowned Medical Advisors, Dr June Chin, and Dr Jessica Knox
Ryan Allway
August 10th, 2021
News
The consultants strategically improve ZIPPZ’s unique and personalized scientific CBD therapies
Menlo Park, CA – News Direct – ZIPPZ
ZIPPZ, the first personalized natural CBD wellness company of its kind, has announced the addition of two renowned medical cannabis consultants to the brand: Dr. June Chin and Dr. Jessica Knox, both cannabinoid and preventive medicine practitioners. With cannabis growing more widely, with 22.2 million users every month, the U.S. legal market is projected to hit $ 43 billion by 2025 in high-quality remedies.
ZIPPZ is revolutionizing the sleep and stress market and offers an alternative to OTC and Rx therapies with innovative CBD and herbal solutions. With the approach based on natural pharmacology from their practices, Dr. Chin and Dr. Knox apply their knowledge to help ZIPPZ upgrade cannabis as a holistic medical alternative.
“ZIPPZ understands that sleep disorders and increased levels of stress and anxiety in different people are driven by dramatically different factors,” said Scott Eagle, CEO of ZIPPZ’s one-size-fits-all approach. We are pleased to meet Dr. Chin and Dr. To welcome Knox to accompany our customer-specific solutions and to advance our mission as an integrative medical approach. “
“As a chronic pain survivor, I have advocated the use of medicinal cannabis throughout my career,” said Dr. Chin. “More inclusive and holistic approaches to patient care are exactly what we need. I am honored to work with the ZIPPZ team to advance this important vision while developing affordable and personalized CBD therapies for those seeking relief from stress and pain.“
As part of ZIPPZ’s unique approach, the brand uses the solid online rating of each customer to get a nuanced understanding of their individual condition, severity, age, gender and lifestyle. ZIPPZ then personalizes individual recipe recommendations for each individual and offers a “sample” program in which users can finalize the perfect ZIPPZ formula for their needs.
Dr. Knox said: “I am particularly fascinated by ZIPPZ’s personalized consumer ratings, as health needs should be taken into account individually. I look forward to using my experience in the advancement of the cannabinoid system and medical applications to advise ZIPPZ in its vision that every customer receives a unique remedy for their health and wellness needs. “
By incorporating principles of network pharmacology, ZIPPZ has maximized the effectiveness of 35 proven botanicals, including CBD, to formulate products that meet the individual needs of each consumer. ZIPPZ offers hundreds of possible formula combinations, paving the way for credible and natural wellness therapies that work.
ABOUT ZIPPZ:
ZIPPZ is a California-based CBD wellness company aimed directly at the consumer, offering personalized, scientifically formulated CBD solutions for sleep, stress and anxiety. Founded by a team of doctors, clinicians, scientists and technologists, ZIPPZ rejects the one-size-fits-all approach to CBD therapies. After consumers complete a quick and thorough 3 minute assessment, ZIPPZ uses Data Science to provide them with personalized solutions. Rooted in nature and activated by science, ZIPPZ combines CBD with 35 carefully selected botanicals to deliver therapies tailored to the needs of each individual. As a leader in the revolution in personalized CBD therapies, ZIPPZ offers over 250 product combinations that provide fast and effective relief.
ABOUT DR. JUNE CHIN:
Dr. June Chin is an integrative cannabinoid medical practitioner who graduated from Touro University with a degree in Medicine and a BS in Nutritional and Food Sciences, Biochemistry from Cornell University. She is a board member of the American Academy of Cannabinoid Medicine, the Association for Cannabis Health Equity and Medicine (ACHEM), Co-Founder and Medical Director at Medical Cannabis Mentor, Chief Medical Advisor at CannabisMD.com & Miraculo and Chief Medical Advisor at Artemis CBD-Shop . Dr. Chin is also a chronic pain survivor. Based on her experience, Dr. Chin dedicates her medical career to finding effective, inclusive, and holistic approaches to patient care. Dr. Chin is also a frequent keynote speaker on the science and medicine of cannabis and has spoken in hospitals, conferences, and events around the world.
ABOUT DR.JESSICA KNOX:
Dr. Jessica Knox is a Specialist in Preventive Medicine who graduated from Harvard University with a bachelor’s degree prior to completing her medical and business degrees from Tufts University. After completing her specialist training in preventive medicine, Dr. Knox completed her studies of the endocannabinoid system and cannabis medicine. She has spoken on numerous medical cannabis panels, presented at cannabis conferences nationwide, and has appeared on national television programs and global webcasts to discuss the emerging fields of Endocannabinology ™ and cannabinoid medicine. Dr. Knox is Co-Founder and CEO of American Cannabinoid Clinics and Co-Founder of Pivital Edu. She is also a co-founder and board member of the Association for Cannabis Health Equity and Medicine (ACHEM).
—
To learn more, visit: zipz.com.
* Statistics from ‘CDC’, Marijuana Fast Facts and Fact Sheets and ‘Intrado Global Newswire’ included: Cannabis Capital triples to USD 6 billion in the first half of 2021
Contact details
Live PR + digital
Lynsey Gray
+1 250-505-6434
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
MediPharm is a pioneer in the cannabis industry as it is the first company in Canada to successfully become a Licensed Producer for cannabis oil production without first receiving a cannabis cultivation license.
Flora is building a connected, design-led collective, of plant-based wellness and lifestyle brands, that delivers the most compelling customer experiences in the world, one community at a time.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
